vyndaqel
pfizer europe ma eeig - tafamidis - amyloidose - andre narkotika stoffer - vyndaqel er indiceret til behandling af transthyretinamyloidose hos voksne patienter med fase 1-symptomatisk polyneuropati for at forsinke perifer neurologisk nedsat funktion.
indapamid "ratiopharm" 1,5 mg depottabletter
ratiopharm gmbh - indapamid (vandfri) - depottabletter - 1,5 mg
giona easyhaler 100 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 100 mikrogram/dosis
giona easyhaler 200 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 200 mikrogram/dosis
budehal 400 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 400 mikrogram/dosis
budenofalk 9 mg enterogranulat
dr. falk pharma gmbh - budesonid - enterogranulat - 9 mg
budenofalk 3 mg enterokapsler, hårde
dr. falk pharma gmbh - budesonid - enterokapsler, hårde - 3 mg
budenofalk 2 mg rektalskum
dr. falk pharma gmbh - budesonid - rektalskum - 2 mg
budesonid "2care4" 64 mikrogram/dosis næsespray, suspension
2care4 aps - budesonid - næsespray, suspension - 64 mikrogram/dosis
budesonid "europharma" 200 mikrogram/dosis inhalationspulver
europharma.dk aps - budesonid - inhalationspulver - 200 mikrogram/dosis